Preventive healthcare in Europe is gaining momentum, yet millions of people continue to fall through the cracks of traditional medical systems. Milan based Qura is positioning itself to change that dynamic. The AI powered health platform has closed a €1.5 million pre seed funding round to build a new care model aimed at people living with persistent but often overlooked health issues.
The round was led by United Ventures and included participation from Vento, Italian Angels for Growth and several individual angel investors. The funding will support team expansion, technology development and early international growth as Qura works to establish a new standard for preventive and continuous care.
The Growing Gap in Everyday Health Care
An estimated one in five adults experiences ongoing subclinical symptoms such as fatigue, digestive discomfort, hormonal imbalance or unexplained hair loss. While these issues may not qualify as acute illness, they can significantly reduce quality of life. However, existing healthcare structures are largely designed for emergencies and acute conditions, leaving early intervention and long term monitoring under supported.
Primary care consultations are often short and fragmented, diagnostics may be limited, and patients frequently move between specialists without a coordinated plan. As a result, many people turn to private testing or wellness services that lack medical continuity or evidence based follow up.
At the same time, Europe’s health check up market is expected to reach €18.6 billion by 2030, reflecting growing public interest in prevention. Qura aims to meet this demand with a clinically grounded alternative that bridges the gap between wellness and medicine.
A Hybrid Model Combining AI and Physicians
Qura delivers an integrated care pathway designed to support early detection, long term monitoring and personalised intervention. Members begin with comprehensive blood testing through partner laboratories. These results are then analysed using Qura’s AI driven health intelligence, which helps identify patterns and potential risks across multiple systems.
Each user receives a 45 minute consultation with a dedicated physician, who reviews the data and develops a tailored health plan. This plan outlines immediate actions, longer term monitoring strategies and follow up recommendations, supported by ongoing medical guidance.
Rather than replacing doctors, Qura positions AI as an enabling layer that improves efficiency, insight and personalisation. Physicians remain central to care delivery, a model the company believes is essential for trust, adherence and clinical quality.
Built for Europe’s Regulatory Landscape
From the outset, Qura has focused on building an EU native healthcare platform. The infrastructure is designed to be GDPR compliant, medically validated and integrated with local laboratory networks. This regulatory first approach is intended to support scalability across European markets while maintaining high standards for data protection and clinical oversight.
Virginia Gambardella, CEO and founder of Qura, said that many people sense something is wrong with their health but lack the tools or guidance to act.
“Health is still treated as an emergency rather than a priority. We combine the precision of AI with the trust of a real doctor to help people stay well, not just recover when something goes wrong,” she said.
Scaling the Platform Across Europe
The new funding will be used to expand Qura’s medical, engineering and operations teams, advance its AI health intelligence capabilities and invest in digital marketing and community led growth. The company is also preparing for expansion into additional European markets, building on its early traction in Italy.
By addressing prevention, continuity and personalisation in a single platform, Qura is aiming to reshape how healthcare supports people long before illness becomes unavoidable.
